A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer

NCT01732380 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Inoperable Esophageal Cancer Stage I-III

Interventions

DRUG: Raltitrexed
DRUG: Oxaliplatin
RADIATION: Radiotherapy

Sponsor

The First People's Hospital of Lianyungang

Collaborators

[object Object]
[object Object]
[object Object]